TCF7L2 gene polymorphisms do not predict susceptibility to diabetes in tropical calcific pancreatitis but may interact with SPINK1 and CTSB mutations in predicting dia
详细信息 查看全文
- 作者：Swapna Mahurkar (1)
Seema Bhaskar (1)
D Nageshwar Reddy (2)
Swami Prakash (1)
G Venkat Rao (2)
Shivaram Prasad Singh (3)
Varghese Thomas (4)
Giriraj Ratan Chandak (1) - 刊名：BMC Medical Genetics
- 出版年：2008
- 出版时间：December 2008
- 年：2008
- 卷：9
- 期：1
- 全文大小：275KB
- 参考文献：1. Barman KK, Premalatha G, Mohan V: Tropical chronic pancreatitis. / Postgrad Med J 2003, 79:606-5. CrossRef
2. Reddy DN: Tropical pancreatitis. The Indian Experience. / Proceedings of the 8th World Congress of the International Gastro-Surgical Club, 15-8 April Strasbourg, France 1998, 249-53.
3. Mohan V, Snehalatha C, Ramachandran A, Jayashree R, Viswanathan M: Pancreatic beta cell function in tropical pancreatic diabetes. / Metabolism 1983, 32:1091-2. CrossRef
4. Mohan V, Ramachandran A, Vijay Kumar G, Snehalatha C, Viswanathan M: Insulin resistance in fibrocalculous (tropical) pancreatic diabetes. / Horm Metab Res 1988,20(12):746-8. CrossRef
5. Mehrotra RN, Bhatia E, Choudhury G: Beta cell function and insulin sensitivity in tropical calcific pancreatitis from North India. / Metabolism 1997,46(4):441-4. CrossRef
6. Bank S, Marks IN, Vinik AI: Clinical and hormonal aspects of pancreatic diabetes. / Am J Gastroenterol 1975,64(1):13-2.
7. Mohan R, Rajendran B, Mohan V, Ramachandran A, Viswanathan M, Kohner EM: Retinopathy in tropical pancreatic diabetes. / Diabetes Care 1987 ,10(4):532-33.
8. Ramachandran A, Mohan V, Kumaravel TS, Velmurugendran CU, Snehalatha C, Chinnikrishnudu M, Viswanathan M: Peripheral neuropathy in tropical pancreatic diabetes. / Acta Diabetol Lat 1986 ,23(2):135-40. CrossRef
9. Yajnik CS, Shelgikar KM, Naik SS, Kanitkar SV, Orskov H, Alberti KG, Hockaday TD: The ketosis resistance in Fibrocalculous Pancreatic Diabetes 1. Clinical observations and endocrine metabolic measurements during oral glucose tolerance test. / Diab Res Clin Pract 1992, 15:145-6. CrossRef
10. Mohan V, Mohan R, Susheela L, Snehalatha C, Bharani G, Mahajan VK, Ramachandran A, Viswanathan M, Kohner EM: Tropical pancreatic diabetes in South India: heterogeneity in clinical and biochemical profile. / Diabetologia 1985, 28:229-2. CrossRef
11. Chandak GR, Idris MM, Reddy DN, Bhaskar S, Sriram PV, Singh L: Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. / J Med Genet 2002,39(5):347-1. CrossRef
12. Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, Witt H: Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. / Gastroenterology 2002, 123:1020-. CrossRef
13. Hassan Z, Mohan V, Ali L, Allotey R, Barakat K, Faruque MO, Deepa R, McDermott MF, Jackson AE, Cassell P, Curtis D, Gelding SV, Vijayaravaghan S, Gyr N, Whitcomb DC, Khan AK, Hitman GA: SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. / Am J Hum Genet 2002, 71:964-. CrossRef
14. Rossi L, Pfutzer RH, Parvin S, Ali L, Sattar S, Kahn AK, Gyr N, Whitcomb DC: SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. / Pancreatology 2001, 1:242-. CrossRef
15. Schneider A, Suman A, Rossi L, Barmada MM, Beglinger C, Parvin S, Sattar S, Ali L, Khan AK, Gyr N, Whitcomb DC: SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. / Gastroenterology 2002, 123:1026-0. CrossRef
16. Bhatia E, Durie P, Zielenski J, Lam D, Sikora SS, Choudhuri G, Tsui LC: Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis. / Am J Gastroenterol 2000, 95:3658-9. CrossRef
17. Mahurkar S, Idris MM, Reddy DN, Bhaskar S, Rao GV, Thomas V, Singh L, Chandak GR: Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. / Gut 2006,55(9):1270-5. CrossRef
18. Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvari B, / et al.: Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. / Nat Genet 2008,40(1):78-2. CrossRef
19. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, / et al.: Variant of transcription factor 7-like 2 ( TCF7L2 ) gene confers risk of type 2 diabetes. / Nat Genet 2006, 38:320-3. CrossRef
20. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT, Frayling TM, Yajnik CS: Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. / Diabetologia 2007, 50:63-7. CrossRef
21. Bodhini D, Radha V, Dhar M, Narayani N, Mohan V: The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. / Metabolism 2007,56(9):1174-8. CrossRef
22. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, Balkau B, Charpentier G, Pattou F, Stetsyuk V, Scharfmann R, Staels B, Fruhbeck G, Froguel P: Transcription factor TCF7L2 genetic study in French population. / Diabetes 2006, 55:2903-8. CrossRef
23. Groves CJ, Zeggini E, Minton J, Frayling TM, Weedon MN, / et al.: Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. / Diabetes 2006,55(9):2640-4. CrossRef
24. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU: Association of transcription factor 7-like 2 ( TCF7L2 ) variants with type 2 diabetes in a Finnish sample. / Diabetes 2006, 55:2649-3. CrossRef
25. Weedon MN: The importance of TCF7L2 . / Diabet Med 2007, 24:1062-6. CrossRef
26. Yi F, Brubaker PL, Jin T: TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. / J Biol Chem 2005,280(2):1457-4. CrossRef
27. Qu H, Polychronakos C: The TCF7L2 locus and type 1 diabetes. / BMC Med Genet 2007, 8:51. CrossRef
28. WHO Study Group Report on Diabetes Mellitus: WHO technical report series 727. Geneva: WHO 1985.
29. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. / Am J Hum Genet 2002,70(2):425-4. CrossRef
30. Cochran WG: Some methods for strengthening the common χ2 tests. / Biometrics 1954, 10:417-51. CrossRef
31. Wilkin TJ: The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. / Diabetologia 2001,44(7):914-2. CrossRef
32. Field SF, Howson JM, Smyth DJ, Walker NM, Dunger DB, Todd JA: Analysis of the type 2 diabetes gene, TCF7L2 , in 13,795 type 1 diabetes cases and control subjects. / Diabetologia 2007,50(1):212-3. CrossRef
33. Zhang C, Qi L, Hunter DJ, Meigs JB, Manson JE, van Dam RM, Hu FB: Variant of Transcription Factor 7-Like 2 ( TCF7L2 ) Gene and the Risk of Type 2 Diabetes in Large Cohorts of U.S. Women and Men. / Diabetes 2006, 55:2645-8. CrossRef
34. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/9/80/prepub - 作者单位：Swapna Mahurkar (1)
Seema Bhaskar (1)
D Nageshwar Reddy (2)
Swami Prakash (1)
G Venkat Rao (2)
Shivaram Prasad Singh (3)
Varghese Thomas (4)
Giriraj Ratan Chandak (1)
1. Genome Research Group, Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad, India
2. Asian Institute of Gastroenterology, Punjagutta, Hyderabad, India
3. Department of Gastroenterology, SCB Medical College, Cuttack, India
4. Department of Gastroenterology, Calicut Medical College, Calicut, India - ISSN：1471-2350
文摘
Background Tropical calcific pancreatitis (TCP) is a type of chronic pancreatitis unique to developing countries in tropical regions and one of its important features is invariable progression to diabetes, a condition called fibro-calculous pancreatic diabetes (FCPD), but the nature of diabetes in TCP is controversial. We analysed the recently reported type 2 diabetes (T2D) associated polymorphisms in the TCF7L2 gene using a case-control approach, under the hypothesis that TCF7L2 variants should show similar association if diabetes in FCPD is similar to T2D. We also investigated the interaction between the TCF7L2 variants and N34S SPINK1 and L26V CTSB mutations, since they are strong predictors of risk for TCP. Methods Two polymorphisms rs7903146 and rs12255372 in the TCF7L2 gene were analyzed by direct sequencing in 478 well-characterized TCP patients and 661 healthy controls of Dravidian and Indo-European ethnicities. Their association with TCP with diabetes (FCPD) and without diabetes was tested in both populations independently using chi-square test. Finally, a meta analysis was performed on all the cases and controls for assessing the overall significance irrespective of ethnicity. We dichotomized the whole cohort based on the presence or absence of N34S SPINK1 and L26V CTSB mutations and further subdivided them into TCP and FCPD patients and compared the distribution of TCF7L2 variants between them. Results The allelic and genotypic frequencies for both TCF7L2 polymorphisms, did not differ significantly between TCP patients and controls belonging to either of the ethnic groups or taken together. No statistically significant association of the SNPs was observed with TCP or FCPD or between carriers and non-carriers of N34S SPINK1 and L26V CTSB mutations. The minor allele frequency for rs7903146 was different between TCP and FCPD patients carrying the N34S SPINK1 variant but did not reach statistical significance (OR = 1.59, 95% CI = 0.93-.70, P = 0.09), while, TCF7L2variant showed a statistically significant association between TCP and FCPD patients carrying the 26V allele (OR = 1.69, 95% CI = 1.11-.56, P = 0.013). Conclusion Type 2 diabetes associated TCF7L2 variants are not associated with diabetes in TCP. Since, TCF7L2 is a major susceptibility gene for T2D, it may be hypothesized that the diabetes in TCP patients may not be similar to T2D. Our data also suggests that co-existence of TCF7L2 variants and the SPINK1 and CTSB mutations, that predict susceptibility to exocrine damage, may interact to determine the onset of diabetes in TCP patients.